Dapagliflozin Tablet
Product Images NDC 71921-421

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Dapagliflozin (NDC 71921-421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Dapagliflozin 01)

Chemical structure of Dapagliflozin, showing a glucose moiety linked to a chlorophenyl and ethoxyphenyl group, illustrating the molecular composition of the active ingredient in the DAPAGLIFLOZIN tablets by Florida Pharmaceutical Products, LLC.*

FDA Label Image

Image (Dapagliflozin 02)

A scatter plot graph showing 24-hour urinary glucose (g) versus dapagliflozin dose (mg) on a logarithmic scale. It displays observed values and fitted lines for healthy subjects and subjects with type 2 diabetes mellitus (T2DM). The data points differentiate between these two groups using different markers.*

FDA Label Image

Image (Dapagliflozin 03)

A line graph showing adjusted mean change from baseline in HbA1c (%) over 24 weeks of study. The x-axis represents study weeks from 0 to 24, and the y-axis shows percentage change in HbA1c from 0 to -2.0%. Three data series are plotted with different markers, indicating distinct treatment groups or conditions with their corresponding mean changes and error bars.*

FDA Label Image

Image (Dapagliflozin 04)

A line graph depicting the percentage change in HbA1c levels from baseline over 24 study weeks. The y-axis shows HbA1c percentage change, and the x-axis shows study weeks from 0 to 24. Two data series with markers (squares and triangles) track HbA1c changes, showing a decline from baseline to week 24 with error bars at the 24-week point (LOCF).*

FDA Label Image

Image (Dapagliflozin 05)

A line graph comparing the percentage of patients with an event over 60 months from randomization between Dapagliflozin tablets and placebo groups. The x-axis shows months from randomization, and the y-axis shows the percentage of patients with the event, with Dapagliflozin showing a lower event rate than placebo over time.*

FDA Label Image

Image (Dapagliflozin 06)

A line chart depicting the percentage of patients with events over 60 months from randomization, comparing Dapagliflozin tablets and placebo. The y-axis represents the percentage of patients with events, and the x-axis shows the months from randomization. The placebo group shows a higher event rate compared to the Dapagliflozin tablets group throughout the time period.*

FDA Label Image

Desc (Dapagliflozin 07)

Label for Dapagliflozin Tablets 5 mg by Florida Pharmaceutical Products, LLC. The label states the product contains 5 mg dapagliflozin per film-coated tablet, with a package size of 30 tablets. Storage instructions specify 20°C to 25°C with excursions allowed between 15°C and 30°C. Manufactured by Inventia Healthcare Limited, India. Includes NDC 71921-420-33 and barcode.*

FDA Label Image

Desc (Dapagliflozin 08)

Label for Dapagliflozin Tablets, 5 mg strength, film-coated oral tablets in a package of 90 tablets. The label states prescription use only and includes storage instructions (20°C to 25°C, with permitted excursions), dispensing guidance, manufacturer Inventia Healthcare Limited in India, and labeler Florida Pharmaceutical Products, LLC in Boca Raton, FL. Includes a barcode and batch printing area.*

FDA Label Image

Desc (Dapagliflozin 09)

Label for Dapagliflozin Tablets 5 mg oral tablets from Florida Pharmaceutical Products, LLC. The label indicates a package size of 500 tablets, includes storage instructions, manufacturer details (Inventia Healthcare Limited, India), and a barcode. It highlights a pharmacist instruction to dispense the medication guide to each patient and emphasizes a check for the inner seal of the bottle.*

FDA Label Image

Desc (Dapagliflozin 10)

Label for Dapagliflozin Tablets 10 mg oral tablets, presented in a container of 30 tablets. The label includes storage instructions, manufacturing details by Inventia Healthcare Limited in India, and specifies the product is manufactured for Florida Pharmaceutical Products, LLC. The label features a barcode and measurements for printing purposes.*

FDA Label Image

Desc (Dapagliflozin 11)

Label for Dapagliflozin Tablets 10 mg oral dosage form by Florida Pharmaceutical Products, LLC. The label indicates a quantity of 90 tablets and includes storage instructions, manufacturing details by Inventia Healthcare Limited, a barcode, and a pharmacist dispensing note. Dimensions of the label are approximately 97.0 mm by 26.5 mm.*

FDA Label Image

Desc (Dapagliflozin 12)

Label for Dapagliflozin Tablets 10 mg oral tablets, containing 500 tablets per container. Manufactured for Florida Pharmaceutical Products, LLC, with manufacturing by Inventia Healthcare Limited in India. The label includes NDC 71921-421-50, storage instructions at 20°C to 25°C, and a pharmacist note to dispense the medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.